Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03751059Phase 4Unknown
Phase 4, randomised trial of bromfenac sodium in open-angle glaucoma (OAG) (2 arms). Primary endpoint: Target Intraocular Pressure at 12 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03751059.